Search research articles
Contact Us
Filters
Showing results (71-80 of 124) with videos related to
Page
of 13
Sort By:
HIV Research & Clinical Practice
|
July 23, 2025
Cardiovascular risk and achievement of target levels in low-density lipoprotein cholesterol in people living with HIV: insights from the DUALIS study
Florian Voit, Sven Breitschwerdt, Annamaria Balogh, et al.
Current Biology : CB
|
December 30, 2022
A novel period mutation implicating nuclear export in temperature compensation of the Drosophila circadian clock
Astrid Giesecke, Peter S Johnstone, Angelique Lamaze, et al.
Advances in Pharmacological Sciences
|
January 29, 2019
Tenofovir Disoproxil Fumarate Is Associated with a Set-Point Variation in the Calcium-Parathyroid Hormone-Vitamin D Axis: Results from a German Cohort
Sebastian Noe, Silke Heldwein, Carmen Wiese, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
October 20, 2009
Prior therapy influences the efficacy of lamivudine monotherapy in patients with lamivudine-resistant HIV-1 infection
Milos Opravil, Thomas Klimkait, Severine Louvel, et al.
Journal of the International AIDS Society
|
November 15, 2014
144-week outcomes of lopinavir/ritonavir (LPV/r)-based first-line ART in 1,409 HIV-infected patients: data from the German STAR/STELLA cohort
Eva Wolf, Andreas Trein, Axel Baumgarten, et al.
Patient Preference and Adherence
|
November 30, 2017
Highly specific reasons for nonadherence to antiretroviral therapy: results from the German adherence study
Johanna Boretzki, Eva Wolf, Carmen Wiese, et al.
The Journal of Antimicrobial Chemotherapy
|
July 8, 2020
Adequate plasma levels of dolutegravir in combination with ritonavir-boosted darunavir: a pharmacokinetic subgroup analysis of the DUALIS study
Simon Weidlich, Christoph Boesecke, Jochen Schneider, et al.
The Journal of Antimicrobial Chemotherapy
|
September 2, 2017
Pharmacokinetics of once-daily dolutegravir and ritonavir-boosted darunavir in HIV patients: the DUALIS study
Christoph D Spinner, Tim Kümmerle, Ivanka Krznaric, et al.
Plos Biology
|
July 4, 2008
Human and Drosophila cryptochromes are light activated by flavin photoreduction in living cells
Nathalie Hoang, Erik Schleicher, Sylwia Kacprzak, et al.
Molecular Cell
|
January 5, 2005
Crystal structure and interactions of the PAS repeat region of the Drosophila clock protein PERIOD
Ozkan Yildiz, Masao Doi, Irene Yujnovsky, et al.
Page
of 13
Search research articles
Search
Showing results (71-80 of 124) with videos related to
Sort By:
Page
of 13
HIV Research & Clinical Practice
|
July 23, 2025
Cardiovascular risk and achievement of target levels in low-density lipoprotein cholesterol in people living with HIV: insights from the DUALIS study
Florian Voit, Sven Breitschwerdt, Annamaria Balogh, et al.
Current Biology : CB
|
December 30, 2022
A novel period mutation implicating nuclear export in temperature compensation of the Drosophila circadian clock
Astrid Giesecke, Peter S Johnstone, Angelique Lamaze, et al.
Advances in Pharmacological Sciences
|
January 29, 2019
Tenofovir Disoproxil Fumarate Is Associated with a Set-Point Variation in the Calcium-Parathyroid Hormone-Vitamin D Axis: Results from a German Cohort
Sebastian Noe, Silke Heldwein, Carmen Wiese, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
October 20, 2009
Prior therapy influences the efficacy of lamivudine monotherapy in patients with lamivudine-resistant HIV-1 infection
Milos Opravil, Thomas Klimkait, Severine Louvel, et al.
Journal of the International AIDS Society
|
November 15, 2014
144-week outcomes of lopinavir/ritonavir (LPV/r)-based first-line ART in 1,409 HIV-infected patients: data from the German STAR/STELLA cohort
Eva Wolf, Andreas Trein, Axel Baumgarten, et al.
Patient Preference and Adherence
|
November 30, 2017
Highly specific reasons for nonadherence to antiretroviral therapy: results from the German adherence study
Johanna Boretzki, Eva Wolf, Carmen Wiese, et al.
The Journal of Antimicrobial Chemotherapy
|
July 8, 2020
Adequate plasma levels of dolutegravir in combination with ritonavir-boosted darunavir: a pharmacokinetic subgroup analysis of the DUALIS study
Simon Weidlich, Christoph Boesecke, Jochen Schneider, et al.
The Journal of Antimicrobial Chemotherapy
|
September 2, 2017
Pharmacokinetics of once-daily dolutegravir and ritonavir-boosted darunavir in HIV patients: the DUALIS study
Christoph D Spinner, Tim Kümmerle, Ivanka Krznaric, et al.
Plos Biology
|
July 4, 2008
Human and Drosophila cryptochromes are light activated by flavin photoreduction in living cells
Nathalie Hoang, Erik Schleicher, Sylwia Kacprzak, et al.
Molecular Cell
|
January 5, 2005
Crystal structure and interactions of the PAS repeat region of the Drosophila clock protein PERIOD
Ozkan Yildiz, Masao Doi, Irene Yujnovsky, et al.
Page
of 13